Nature Communications (Jan 2018)

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

  • Pengju Wang,
  • Xiaozhu Li,
  • Jiwei Wang,
  • Dongling Gao,
  • Yuenan Li,
  • Haoze Li,
  • Yongchao Chu,
  • Zhongxian Zhang,
  • Hongtao Liu,
  • Guozhong Jiang,
  • Zhenguo Cheng,
  • Shengdian Wang,
  • Jianzeng Dong,
  • Baisui Feng,
  • Louisa S Chard,
  • Nicholas R Lemoine,
  • Yaohe Wang

DOI
https://doi.org/10.1038/s41467-017-02205-9
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 1

Abstract

Read online

The originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as ‘n’ and ‘u’, respectively. These errors have now been corrected in both the PDF and HTML versions of the Article.